Stark P - Search Results

1

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Herbrecht R, et al. Among authors: stark p. N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191. N Engl J Med. 2002. PMID: 12167683 Free article. Clinical Trial.

2

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH. Greene RE, et al. Among authors: stark p. Clin Infect Dis. 2007 Feb 1;44(3):373-9. doi: 10.1086/509917. Epub 2006 Dec 29. Clin Infect Dis. 2007. PMID: 17205443

3

Attributable mortality of Stenotrophomonas maltophilia bacteremia.

Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Senol E, et al. Clin Infect Dis. 2002 Jun 15;34(12):1653-6. doi: 10.1086/340707. Epub 2002 May 24. Clin Infect Dis. 2002. PMID: 12032905

4

Comparison of preoperative computed tomography and surgical findings in maxillofacial infections.

Rosenthal M, Oreadi D, Kraus J, Bedi H, Stark PC, Shastri K. Rosenthal M, et al. J Oral Maxillofac Surg. 2011 Jun;69(6):1651-6. doi: 10.1016/j.joms.2010.07.034. Epub 2011 Jan 21. J Oral Maxillofac Surg. 2011. PMID: 21256641

5

Multimodality management of Merkel cell carcinoma.

Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, Souba WW. Ott MJ, et al. Among authors: stark p. Arch Surg. 1999 Apr;134(4):388-92; discussion 392-3. doi: 10.1001/archsurg.134.4.388. Arch Surg. 1999. PMID: 10199311

6

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease. Jafar TH, et al. Among authors: stark pc. Kidney Int. 2001 Sep;60(3):1131-40. doi: 10.1046/j.1523-1755.2001.0600031131.x. Kidney Int. 2001. PMID: 11532109 Free article. Clinical Trial.

7

ELISA test for p63 antibodies in chronic ulcerative stomatitis.

Solomon LW, Stark PC, Winter L, Kumar V, Sinha S. Solomon LW, et al. Among authors: stark pc. Oral Dis. 2010 Mar;16(2):151-5. doi: 10.1111/j.1601-0825.2009.01606.x. Epub 2009 Aug 3. Oral Dis. 2010. PMID: 19682320

8

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.

Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, Ott MJ. Shebani KO, et al. Among authors: stark pc. Ann Surg. 1999 Jun;229(6):815-21; discussion 822-3. doi: 10.1097/00000658-199906000-00008. Ann Surg. 1999. PMID: 10363895 Free PMC article.

9

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group. Jafar TH, et al. Ann Intern Med. 2003 Aug 19;139(4):244-52. doi: 10.7326/0003-4819-139-4-200308190-00006. Ann Intern Med. 2003. PMID: 12965979

10

The end stage renal disease program.

Stark P. Stark P. N Engl J Med. 1993 Jul 8;329(2):140. N Engl J Med. 1993. PMID: 8510702 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page